Ascendis Pharma (ASND) and Royalty Pharma (RPRX) Enter $150M Royalty Funding Agreement
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
| Asianada, Inc. (NASDAQ: ASND) | Delayed: 242.99 +4.09 (1.71%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $238.90 | 52 Week High | $21.79 | |||
| Open | $239.38 | 52 Week Low | $11.92 | |||
| Day High | $243.87 | P/E | N/A | |||
| Day Low | $236.87 | EPS | $-0.07 | |||
| Volume | 539,164 | |||||
| REPROS THERAPEUTICS (NASDAQ: RPRX) | Delayed: 63.75 +1.60 (2.57%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $62.15 | 52 Week High | $3.48 | |||
| Open | $62.34 | 52 Week Low | $0.80 | |||
| Day High | $63.84 | P/E | N/A | |||
| Day Low | $62.34 | EPS | $-1.54 | |||
| Volume | 2,808,458 | |||||
